Development and clinical validity of a novel blood-based molecular biomarker for subclinical acute rejection following kidney transplant
John J. Friedewald(Northwestern University), Michaël Abécassis(University of Arizona), Manoj Kandpal(Northwestern University), Sunil M. Kurian(Scripps Clinic), Emilio D. Poggio(Cleveland Clinic), Nedjema Sustento‐Reodica(Northwestern University), Jonah Odim(National Institutes of Health), Lihui Zhao(University of Shanghai for Science and Technology), Prabhakar K. Baliga(Medical University of South Carolina), Christopher L. Marsh(Scripps Health), David Iklé(Rho (United States)), Raymond L. Heilman(Mayo Clinic Hospital), S. Brietigam(Northwestern University), Merideth M. Brown(National Institute of Allergy and Infectious Diseases), Brian Armstrong(Rho (United States)), Thomas Whisenant(University of California San Diego), Daniel R. Salomon(Google (United States)), Jane Charette(Northwestern University)
Cited by 156
Related Papers
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
|Hepatology|2018|4.7k
AASLD guidelines for the treatment of hepatocellular carcinoma
|Hepatology|2017|4.2k
The Banff 97 working classification of renal allograft pathology
|Kidney International|1999|3.1k
The International Position on Laparoscopic Liver Surgery
|Annals of Surgery|2009|1.5k